D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia

Kevin N. Boyd, Richard B. Mailman

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)
Original languageEnglish (US)
Title of host publicationTargets and Emerging Therapies for Schizophrenia
PublisherJohn Wiley and Sons
Pages51-84
Number of pages34
ISBN (Print)9780470322826
DOIs
StatePublished - Jun 24 2012

Fingerprint

Drug therapy
Dopamine Agonists

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Boyd, K. N., & Mailman, R. B. (2012). D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia. In Targets and Emerging Therapies for Schizophrenia (pp. 51-84). John Wiley and Sons. https://doi.org/10.1002/9781118309421.ch3
Boyd, Kevin N. ; Mailman, Richard B. / D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia. Targets and Emerging Therapies for Schizophrenia. John Wiley and Sons, 2012. pp. 51-84
@inbook{9bfa1059515b460ca4b3f6b9bf50ac60,
title = "D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia",
author = "Boyd, {Kevin N.} and Mailman, {Richard B.}",
year = "2012",
month = "6",
day = "24",
doi = "10.1002/9781118309421.ch3",
language = "English (US)",
isbn = "9780470322826",
pages = "51--84",
booktitle = "Targets and Emerging Therapies for Schizophrenia",
publisher = "John Wiley and Sons",

}

Boyd, KN & Mailman, RB 2012, D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia. in Targets and Emerging Therapies for Schizophrenia. John Wiley and Sons, pp. 51-84. https://doi.org/10.1002/9781118309421.ch3

D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia. / Boyd, Kevin N.; Mailman, Richard B.

Targets and Emerging Therapies for Schizophrenia. John Wiley and Sons, 2012. p. 51-84.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia

AU - Boyd, Kevin N.

AU - Mailman, Richard B.

PY - 2012/6/24

Y1 - 2012/6/24

UR - http://www.scopus.com/inward/record.url?scp=84886109345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886109345&partnerID=8YFLogxK

U2 - 10.1002/9781118309421.ch3

DO - 10.1002/9781118309421.ch3

M3 - Chapter

AN - SCOPUS:84886109345

SN - 9780470322826

SP - 51

EP - 84

BT - Targets and Emerging Therapies for Schizophrenia

PB - John Wiley and Sons

ER -

Boyd KN, Mailman RB. D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia. In Targets and Emerging Therapies for Schizophrenia. John Wiley and Sons. 2012. p. 51-84 https://doi.org/10.1002/9781118309421.ch3